Evolv Technologies: A Great Product Coupled With A Better Business Model (Rating Upgrade)

Evolv Technologies (EVLV) has experienced a significant stock surge, appreciating 159% in the last six months, largely due to a successful pivot to a Security-as-a-Service subscription model that has driven recurring revenue and gross margin expansion. The company reported robust Q2 2025 results, with revenue up 29% to $32.55 million, annual recurring revenue (ARR) growing 27% to $110.5 million, and achieved positive adjusted EBITDA for the third consecutive quarter, prompting a raised full-year revenue growth guidance to 27-30%. While a new $75 million credit facility will fund a strategic shift to direct fulfillment, which is expected to strengthen customer relationships, it may also lead to short-term gross margin compression and potential EPS misses; however, the author upgrades the stock to a 'Buy' rating, citing substantial long-term upside potential from increasing demand for weapon detection solutions despite ongoing SEC investigation and past product criticisms.

Analysis

Evolv Technologies (EVLV) has demonstrated significant fundamental improvement, driven by a strategic pivot in late 2022 to a 'Security-as-a-Service' subscription model. This shift has fueled a 159% stock appreciation in the last six months, supported by strong Q2 2025 financial results that included a 29% year-over-year revenue increase to $32.55 million and a 27% rise in Annual Recurring Revenue to $110.5 million. The company has now posted its third consecutive quarter of positive adjusted EBITDA, recorded its first positive operating cash flow in five years, and raised full-year revenue guidance to 27-30%. Despite these strengths, significant risks persist. The company faces an ongoing SEC investigation, criticism over the efficacy of its flagship product, and a premium valuation reflected by a Quant value grade of 'F'. Furthermore, a new strategic shift towards 100% direct fulfillment, funded by a $75 million non-dilutive credit facility, is expected to cause short-term gross margin contraction and has led analysts to revise EPS estimates downward. While this move aims to enhance long-term ARR and customer relationships, it introduces near-term profitability headwinds alongside risks of potential stock dilution to service the new debt.

Key Decisions for Investors

• Investors with a long-term growth focus might view the stock's premium valuation as justified by its successful pivot to a recurring revenue model and legislative tailwinds, but should anticipate near-term volatility.
• It is critical to monitor gross margins and EPS results in the upcoming quarters, as the strategic shift to direct fulfillment is projected to cause margin compression, which could lead to earnings misses and create a more attractive entry point.
• Closely track developments related to the ongoing SEC investigation and customer reception of the new 'Evolv Expedite' product, as any negative outcomes could significantly impact market sentiment and the competitive thesis.
• Scrutinize the company's capital management, specifically the potential for future share dilution to service its new $75 million debt, as long-term return models are highly sensitive to this assumption.